CRH PLC (CRH) has shown resilience despite reporting disappointing Q4 earnings, with the stock rising 2.7% on the day of the report. The company is part of the Construction - Raw Materials industry and is rated highly by the Multi-Factor Investor model, indicating strong interest based on low volatility, momentum, and high net payout yields. J.P. Morgan maintains an Overweight rating on CRH, expecting strong fiscal 2025 ebitda growth, supported by solid pricing and operational efficiencies.
The stock is currently trading near the lower Bollinger Band, suggesting it may be oversold. The RSI (14) is at 38.92, indicating potential undervaluation. The MACD is bearish, but the stock is approaching a Fibonacci support level at 92.97.
Recent news highlights CRH's share buyback program, returning $0.3 billion to shareholders, which is a positive signal for investor confidence. Additionally, CRH's annual report indicates a stable financial position and commitment to returning value to shareholders.
Based on the analysis, CRH is expected to rebound next week with a target price of $99.09. The stock is near a Fibonacci support level, and the share buyback program could provide upward momentum.
Buy CRH with a target price of $99.09 and a stop-loss at $92.97. The stock's oversold condition and positive news suggest a potential rebound.
The price of CRH is predicted to go up -23.27%, based on the high correlation periods with GASS. The similarity of these two price pattern on the periods is 93.99%.
CRH
GASS
As the largest roadbuilder in North America, CRH is well positioned to commence public infrastructure projects underpinned by the $1.2 trillion Infrastructure Investment and Jobs Act, which will see a 50% increase in federal highway funding.
CRH's superior outlook to peers is driven by its optimal product mix and a greater contribution of earnings to North America, where demand pressures are milder than in Europe.
Management has been an astute capital allocator and its healthy balance sheet provides plenty of room to increase capital to shareholders or perform M&As.
Citigroup
2025-01-06
Price Target
$120 → $115
Upside
+22.85%
JP Morgan
2024-11-20
Price Target
$114 → $116
Upside
+15.77%
DA Davidson
2024-11-11
Price Target
$110 → $120
Upside
+17.32%